SEC Info - Swartzburg Michael - ‘3’ for 6/10/20 re: Iovance Biotherapeutics, Inc.

<?xml version="1.0" encoding="windows-1252"?>

<issuerName> IOVANCE BIOTHERAPEUTICS, INC. </issuerName>

</issuer>

<rptOwnerName> Swartzburg Michael </rptOwnerName>

</reportingOwnerId>

<rptOwnerStreet1> C/O IOVANCE BIOTHERAPEUTICS, INC. </rptOwnerStreet1>

<rptOwnerStreet2> 999 SKYWAY ROAD, SUITE 150 </rptOwnerStreet2>

<rptOwnerCity> SAN CARLOS </rptOwnerCity>

</reportingOwnerAddress>

<officerTitle> VP, Finance </officerTitle>

</reportingOwnerRelationship>

</reportingOwner>

<value> Stock Option (Right to Buy) </value>

</securityTitle>

</conversionOrExercisePrice>

</exerciseDate>

</expirationDate>

<value> Common Stock </value>

</underlyingSecurityTitle>

</underlyingSecurityShares>

</underlyingSecurity>

</directOrIndirectOwnership>

</ownershipNature>

</derivativeHolding>

<value> Stock Option (Right to Buy) </value>

</securityTitle>

</conversionOrExercisePrice>

</exerciseDate>

</expirationDate>

<value> Common Stock </value>

</underlyingSecurityTitle>

</underlyingSecurityShares>

</underlyingSecurity>

</directOrIndirectOwnership>

</ownershipNature>

</derivativeHolding>

<value> Stock Option (Right to Buy) </value>

</securityTitle>

</conversionOrExercisePrice>

</exerciseDate>

</expirationDate>

<value> Common Stock </value>

</underlyingSecurityTitle>

</underlyingSecurityShares>

</underlyingSecurity>

</directOrIndirectOwnership>

</ownershipNature>

</derivativeHolding>

</derivativeTable>

<footnote id="F1"> Provided the Reporting Person is still employed with the Issuer on the vesting dates, the options are exercisable as follows: (i) options for the purchase of one-third of the granted shares shall vest on the one-year anniversary of March 5, 2018; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of March 5, 2018. </footnote>

<footnote id="F2"> Provided the Reporting Person is still employed with the Issuer on the vesting dates, the options are exercisable as follows: (i) options for the purchase of one-third of the granted shares shall vest on the one-year anniversary of March 4, 2019; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of March 4, 2019. </footnote>

<footnote id="F3"> Provided the Reporting Person is still employed with the Issuer on the vesting dates, the options are exercisable as follows: (i) options for the purchase of one-third of the granted shares shall vest on the one-year anniversary of January 20, 2020; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of January 20, 2020. </footnote>

</footnotes>

<signatureName> /s/ Michael C. Swartzburg </signatureName>

</ownerSignature>

</ownershipDocument>

Swartzburg Michael – ‘3’ for 6/10/20 re: Iovance Biotherapeutics, Inc.

On: Tuesday, 6/23/20, at 9:00pm ET · For: 6/10/20 · Accession #: 1104659-20-76172 · File #: 1-36860

Previous ‘3’: ‘3’ on 12/14/15 for 11/30/15 · Latest ‘3’: This Filing

Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 — SEA’34
Filing Table of Contents

This ‘3’ Document is an XML Data File that may be rendered in various formats:

Swartzburg Michael – ‘3’ for 6/10/20 re: Iovance Biotherapeutics, Inc.

On: Tuesday, 6/23/20, at 9:00pm ET · For: 6/10/20 · Accession #: 1104659-20-76172 · File #: 1-36860

Previous ‘3’: ‘3’ on 12/14/15 for 11/30/15 · Latest ‘3’: This Filing

Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 — SEA’34Filing Table of Contents

This ‘3’ Document is an XML Data File that may be rendered in various formats:

Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 — SEA’34
Filing Table of Contents